SNHG4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.590800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.517800E-01
Normal-vs-Stage2
5.745800E-01
Normal-vs-Stage3
3.774200E-01
Normal-vs-Stage4
4.663200E-01
Stage1-vs-Stage2
3.536600E-01
Stage1-vs-Stage3
6.984300E-02
Stage1-vs-Stage4
1.290010E-01
Stage2-vs-Stage3
7.763500E-03
Stage2-vs-Stage4
1.417560E-02
Stage3-vs-Stage4
7.998500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.688400E-01
Normal-vs-AfricanAmerican
2.091600E-01
Normal-vs-Asian
4.458000E-01
Caucasian-vs-AfricanAmerican
2.134600E-01
Caucasian-vs-Asian
6.995800E-01
AfricanAmerican-vs-Asian
3.003800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.499200E-01
Normal-vs-Female
5.741200E-01
Male-vs-Female
6.811600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.982800E-01
Normal-vs-Age(41-60Yrs)
5.672800E-01
Normal-vs-Age(61-80Yrs)
5.498400E-01
Normal-vs-Age(81-100Yrs)
4.528400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.392600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.085200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.816000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.941200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.260200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.383400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.160200E-01
Normal-vs-Daily Drinker
4.657200E-01
Normal-vs-Weekly Drinker
5.969000E-01
Normal-vs-Occasional Drinker
5.665400E-01
Normal-vs-Social Drinker
3.652000E-01
Non Drinker-vs-Daily Drinker
6.474400E-02
Non Drinker-vs-Weekly Drinker
6.665600E-01
Non Drinker-vs-Occasional Drinker
4.878800E-01
Non Drinker-vs-Social Drinker
7.694600E-01
Daily Drinker-vs-Weekly Drinker
1.984350E-01
Daily Drinker-vs-Occasional Drinker
2.580600E-01
Daily Drinker-vs-Social Drinker
2.327200E-01
Weekly Drinker-vs-Occasional Drinker
8.259800E-01
Weekly Drinker-vs-Social Drinker
8.980600E-01
Occasional Drinker-vs-Social Drinker
7.297400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.405600E-01
Normal-vs-Grade 2
1.610230E-01
Normal-vs-Grade 3
2.434400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.043900E-02
Grade 1-vs-Grade 3
1.688750E-01
Grade 1-vs-Grade 4
3.405600E-01
Grade 2-vs-Grade 3
9.773400E-01
Grade 2-vs-Grade 4
1.610230E-01
Grade 3-vs-Grade 4
2.434400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.623200E-01
Normal-vs-NonDiabetic
5.677000E-01
Diabetic-vs-NonDiabetic
9.214200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.998600E-01
Normal-vs-NoPancreatitis
5.470000E-01
Pancreatitis-vs-NoPancreatitis
1.911570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.325800E-01
Normal-vs-N1
5.318600E-01
N0-vs-N1
2.080200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.609400E-01
Normal-vs-TP53-NonMutant
6.828600E-01
TP53-Mutant-vs-TP53-NonMutant
8.136200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
